Octavio Espinoza, Chief Financial Officer at LIGAND PHARMACEUTICALS INC (LGND), bought 1,500 shares at $103.89 ($156K) on 2025-05-09, disclosed to the SEC on 2025-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.89 | 1,000 | $104K | 66.6% |
| 2 | $104.40 | 500 | $52K | 33.4% |
| Total | $104.06 avg | 1,500 | $156K | 100% |
| Filing → |
| LGND | SELL | 2026-03-06 | $5.5M | — | Filing → |
| LGND | SELL | 2025-12-16 | $679K | — | Filing → |
| LGND | SELL | 2025-03-06 | $575K | — | Filing → |